{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:20:55Z","timestamp":1792783255903,"version":"4.5.0"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 Politecnica delle Marche","id":[{"id":"https:\/\/ror.org\/00x69rs40","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s11154-026-10066-1","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:44:30Z","timestamp":1783655070000},"page":"1091-1107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Natriuretic peptide receptor C in cardiovascular\u2013kidney\u2013liver\u2013metabolic syndrome: from natriuretic peptide deficiency to direct tissue signaling?"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2087-2573","authenticated-orcid":false,"given":"Matteo","family":"Landolfo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1846-7819","authenticated-orcid":false,"given":"Francesco","family":"Spannella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3625-852X","authenticated-orcid":false,"given":"Chiara","family":"Salv\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7034-8155","authenticated-orcid":false,"given":"Bernhard","family":"Radlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2524-5218","authenticated-orcid":false,"given":"Susanne","family":"Kaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6179-5351","authenticated-orcid":false,"given":"Alessandro","family":"Gezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5159-0181","authenticated-orcid":false,"given":"Riccardo","family":"Sarzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"10066_CR1","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American heart association. Circulation. 2023;148:1636\u201364.","journal-title":"Circulation"},{"key":"10066_CR2","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.cgh.2023.09.018","volume":"22","author":"KE Chan","year":"2024","unstructured":"Chan KE, Ong EYH, Chung CH, Ong CEY, Koh B, Tan DJH, et al. Longitudinal outcomes associated with metabolic dysfunction-associated steatotic liver disease: A meta-analysis of 129 studies. Clin Gastroenterol Hepatol. 2024;22:488\u2013e49814.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10066_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2025.103965","volume":"35","author":"J-H Kim","year":"2025","unstructured":"Kim J-H, Lee Y, Nam C-M, Kwon Y-J, Lee J-W. Impact of cardiometabolic risk factors for metabolic dysfunction-associated steatotic liver disease on mortality. Nutr Metab Cardiovasc Dis. 2025;35:103965.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10066_CR4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.85813","author":"CA Arragan Lezama","year":"2025","unstructured":"Arragan Lezama CA, Jaramillo Ramos JJ, Armas Eguiz\u00e1bal DA, Solares Ovando XS, Minera Villagr\u00e1n JC, Males Caiza CJ. Cardiovascular-renal-hepatic-metabolic syndrome: interlinked pathophysiology and integrated management approach. Cureus. 2025. https:\/\/doi.org\/10.7759\/cureus.85813.","journal-title":"Cureus"},{"key":"10066_CR5","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.hlc.2025.08.009","volume":"34","author":"RH Goodheart","year":"2025","unstructured":"Goodheart RH, Ayonrinde OT. Connecting the dots: hepatic steatosis as a central player in the choreography of the liver-cardiovascular-kidney-metabolic syndrome. Heart Lung Circ. 2025;34:1050\u20139.","journal-title":"Heart Lung Circ"},{"key":"10066_CR6","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.jacc.2025.12.015","volume":"87","author":"F Zannad","year":"2026","unstructured":"Zannad F, Khan MS, Bansal N, B\u00f6hm M, Francque SM, Girerd N, et al. <article-title update=\"added\">MASLD, MASH, and the CKM spectrum. J Am Coll Cardiol. 2026;87:2006\u201333.","journal-title":"J Am Coll Cardiol"},{"key":"10066_CR7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41569-020-0381-0","volume":"17","author":"JP Goetze","year":"2020","unstructured":"Goetze JP, Bruneau BG, Ramos HR, Ogawa T, de Bold MK, de Bold AJ. Cardiac natriuretic peptides. Nat Rev Cardiol. 2020;17:698\u2013717.","journal-title":"Nat Rev Cardiol"},{"key":"10066_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214415","volume":"23","author":"R Sarzani","year":"2022","unstructured":"Sarzani R, Allevi M, Di Pentima C, Schiavi P, Spannella F, Giulietti F. Role of cardiac natriuretic peptides in heart structure and function. Int J Mol Sci. 2022;23:14415.","journal-title":"Int J Mol Sci"},{"key":"10066_CR9","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1096\/fasebj.14.10.1345","volume":"14","author":"C Sengen\u00e8s","year":"2000","unstructured":"Sengen\u00e8s C, Berlan M, De Glisezinski I, Lafontan M, Galitzky J. Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J. 2000;14:1345\u201351.","journal-title":"FASEB J"},{"key":"10066_CR10","doi-asserted-by":"publisher","first-page":"C1255","DOI":"10.1152\/ajpcell.00520.2002","volume":"284","author":"H Zhou","year":"2003","unstructured":"Zhou H, Murthy KS. Identification of the G protein-activating sequence of the single-transmembrane natriuretic peptide receptor C (NPR-C). Am J Physiol Cell Physiol. 2003;284:C1255\u201361.","journal-title":"Am J Physiol Cell Physiol"},{"key":"10066_CR11","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.peptides.2004.09.023","volume":"26","author":"B Madhu","year":"2005","unstructured":"Madhu B. Natriuretic peptide receptor-C signaling and regulation. Peptides. 2005;26:1044\u201359.","journal-title":"Peptides"},{"key":"10066_CR12","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00109-010-0641-2","volume":"88","author":"S Rubattu","year":"2010","unstructured":"Rubattu S, Sciarretta S, Morriello A, Calvieri C, Battistoni A, Volpe M. NPR-C: a component of the natriuretic peptide family with implications in human diseases. J Mol Med. 2010;88:889\u201397.","journal-title":"J Mol Med"},{"key":"10066_CR13","doi-asserted-by":"publisher","first-page":"7403","DOI":"10.1073\/pnas.96.13.7403","volume":"96","author":"N Matsukawa","year":"1999","unstructured":"Matsukawa N, Grzesik WJ, Takahashi N, Pandey KN, Pang S, Yamauchi M, et al. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci U S A. 1999;96:7403\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10066_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108708","volume":"262","author":"YA Dickinson","year":"2024","unstructured":"Dickinson YA, Moyes AJ, Hobbs AJ. C-type natriuretic peptide (CNP): the cardiovascular system and beyond. Pharmacol Ther. 2024;262:108708.","journal-title":"Pharmacol Ther"},{"key":"10066_CR15","doi-asserted-by":"publisher","first-page":"e2307882120","DOI":"10.1073\/pnas.2307882120","volume":"120","author":"D Liu","year":"2023","unstructured":"Liu D, Ceddia RP, Zhang W, Shi F, Fang H, Collins S. Discovery of another mechanism for the inhibition of particulate guanylyl cyclases by the natriuretic peptide clearance receptor. Proc Natl Acad Sci U S A. 2023;120:e2307882120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10066_CR16","doi-asserted-by":"publisher","first-page":"13959","DOI":"10.3390\/ijms232213959","volume":"23","author":"L Yu","year":"2022","unstructured":"Yu L, Nouri M-Z, Liu LP, Bala N, Denslow ND, LaDisa JF Jr, et al. C type natriuretic peptide receptor activation inhibits sodium channel activity in human aortic endothelial cells by activating the diacylglycerol-protein kinase C pathway. Int J Mol Sci. 2022;23:13959.","journal-title":"Int J Mol Sci"},{"key":"10066_CR17","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.jacc.2018.12.063","volume":"73","author":"NE Ibrahim","year":"2019","unstructured":"Ibrahim NE, McCarthy CP, Shrestha S, Gaggin HK, Mukai R, Szymonifka J, et al. Effect of neprilysin inhibition on various natriuretic peptide assays. J Am Coll Cardiol. 2019;73:1273\u201384.","journal-title":"J Am Coll Cardiol"},{"key":"10066_CR18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ajhg.2018.06.007","volume":"103","author":"E Boudin","year":"2018","unstructured":"Boudin E, De Jong TR, Prickett TCR, Lapauw B, Toye K, Van Hoof V, et al. Bi-allelic loss-of-function mutations in the NPR-C receptor result in enhanced growth and connective tissue abnormalities. Am J Hum Genet. 2018;103:288\u201395.","journal-title":"Am J Hum Genet"},{"key":"10066_CR19","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac019","volume":"6","author":"P Lauffer","year":"2022","unstructured":"Lauffer P, Boudin E, van der Kaay DCM, Koene S, van Haeringen A, van Tellingen V, et al. Broadening the spectrum of loss-of-function variants in NPR-C-related extreme tall stature. J Endocr Soc. 2022;6:bvac019.","journal-title":"J Endocr Soc"},{"key":"10066_CR20","doi-asserted-by":"publisher","first-page":"18494","DOI":"10.4238\/2015.December.23.37","volume":"14","author":"PY Chang","year":"2015","unstructured":"Chang PY, Liu ZY, Qin L, Zhao P. Association of NPRA and NPRC gene variants and hypertension in Mongolian population. Genet Mol Res. 2015;14:18494\u2013502.","journal-title":"Genet Mol Res"},{"issue":"1","key":"10066_CR21","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12916-023-02867-x","volume":"21","author":"HT Cronj\u00e9","year":"2023","unstructured":"Cronj\u00e9 HT, Karhunen V, Hovingh GK, Coppieters K, Lagerstedt JO, Nyberg M, et al. Genetic evidence implicating natriuretic peptide receptor-3 in cardiovascular disease risk: a Mendelian randomization study. BMC Med. 2023;21:158.","journal-title":"BMC Med"},{"key":"10066_CR22","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1210\/jc.2011-1182","volume":"96","author":"AM Khan","year":"2011","unstructured":"Khan AM, Cheng S, Magnusson M, Larson MG, Newton-Cheh C, McCabe EL, et al. Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. J Clin Endocrinol Metab. 2011;96:3242\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"10066_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10741-011-9249-z","volume":"17","author":"A Clerico","year":"2012","unstructured":"Clerico A, Giannoni A, Vittorini S, Emdin M. The paradox of low BNP levels in obesity. Heart Fail Rev. 2012;17:81\u201396.","journal-title":"Heart Fail Rev"},{"key":"10066_CR24","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/jamacardio.2023.2758","volume":"8","author":"JB Echouffo-Tcheugui","year":"2023","unstructured":"Echouffo-Tcheugui JB, Zhang S, McEvoy JW, Juraschek SP, Fang M, Ndumele CE, et al. Insulin resistance and N-terminal pro-B-type natriuretic peptide among healthy adults. JAMA Cardiol. 2023;8:989\u201395.","journal-title":"JAMA Cardiol"},{"key":"10066_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaf235","author":"S Matsumoto","year":"2025","unstructured":"Matsumoto S, Butt JH, Docherty KF, Jhund PS, Abraham WT, Desai AS, et al. Obesity, aldosterone, and natriuretic peptide in patients with heart failure and reduced ejection fraction. Cardiovasc Res. 2025. https:\/\/doi.org\/10.1093\/cvr\/cvaf235.","journal-title":"Cardiovasc Res"},{"key":"10066_CR26","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.jchf.2024.04.027","volume":"12","author":"T Kondo","year":"2024","unstructured":"Kondo T, Campbell R, Jhund PS, Anand IS, Carson PE, Lam CSP, et al. Low natriuretic peptide levels and outcomes in patients with heart failure and preserved ejection fraction. JACC Heart Fail. 2024;12:1442\u201355.","journal-title":"JACC Heart Fail"},{"key":"10066_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/ejhf\/xuag154","author":"C Gavina","year":"2026","unstructured":"Gavina C, Ferreira JP, Mendes LL, Bernardo F, Gon\u00e7alves S, Pimenta J, et al. Anthropometric adiposity measures and natriuretic peptides in heart failure screening: population-based evidence from the PORTHOS study. Eur J Heart Fail. 2026. https:\/\/doi.org\/10.1093\/ejhf\/xuag154.","journal-title":"Eur J Heart Fail"},{"key":"10066_CR28","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/oby.21418","volume":"24","author":"Z Kovacova","year":"2016","unstructured":"Kovacova Z, Tharp WG, Liu D, Wei W, Xie H, Collins S, et al. Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes. Obes (Silver Spring). 2016;24:820\u20138.","journal-title":"Obes (Silver Spring)"},{"key":"10066_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.trsl.2017.06.001","volume":"186","author":"A Gentili","year":"2017","unstructured":"Gentili A, Frangione MR, Albini E, Vacca C, Ricci MA, De Vuono S, et al. Modulation of natriuretic peptide receptors in human adipose tissue: molecular mechanisms behind the natriuretic handicap in morbidly obese patients. Transl Res. 2017;186:52\u201361.","journal-title":"Transl Res"},{"key":"10066_CR30","doi-asserted-by":"publisher","first-page":"R104","DOI":"10.1152\/ajpregu.00499.2015","volume":"311","author":"M Bordicchia","year":"2016","unstructured":"Bordicchia M, Ceresiani M, Pavani M, Minardi D, Polito M, Wabitsch M, et al. Insulin\/glucose induces natriuretic peptide clearance receptor in human adipocytes: a metabolic link with the cardiac natriuretic pathway. Am J Physiol Regul Integr Comp Physiol. 2016;311:R104\u201314.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10066_CR31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1210\/endrev\/bnac029","volume":"44","author":"M Nyberg","year":"2023","unstructured":"Nyberg M, Terzic D, Ludvigsen TP, Mark PD, Michaelsen NB, Abildstr\u00f8m SZ, et al. A state of natriuretic peptide deficiency. Endocr Rev. 2023;44:379\u201392.","journal-title":"Endocr Rev"},{"key":"10066_CR32","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/dom.16073","volume":"27","author":"J Singh","year":"2025","unstructured":"Singh J, Adel FW, Scott CG, Chen HH. Natriuretic peptide levels and predicting risk of developing new diabetes mellitus and metabolic syndrome. Diabetes Obes Metab. 2025;27:777\u201384.","journal-title":"Diabetes Obes Metab"},{"key":"10066_CR33","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/obr.12598","volume":"18","author":"K Verboven","year":"2017","unstructured":"Verboven K, Hansen D, Jocken JWE, Blaak EE. Natriuretic peptides in the control of lipid metabolism and insulin sensitivity. Obes Rev. 2017;18:1243\u201359.","journal-title":"Obes Rev"},{"key":"10066_CR34","doi-asserted-by":"publisher","first-page":"19324","DOI":"10.1074\/jbc.271.32.19324","volume":"271","author":"MB Anand-Srivastava","year":"1996","unstructured":"Anand-Srivastava MB, Sehl PD, Lowe DG. Cytoplasmic domain of natriuretic peptide receptor-C inhibits adenylyl cyclase. Involvement of a pertussis toxin-sensitive G protein. J Biol Chem. 1996;271:19324\u20139.","journal-title":"J Biol Chem"},{"key":"10066_CR35","doi-asserted-by":"publisher","first-page":"17587","DOI":"10.1074\/jbc.274.25.17587","volume":"274","author":"KS Murthy","year":"1999","unstructured":"Murthy KS, Makhlouf GM. Identification of the G protein-activating domain of the natriuretic peptide clearance receptor (NPR-C). J Biol Chem. 1999;274:17587\u201392.","journal-title":"J Biol Chem"},{"key":"10066_CR36","doi-asserted-by":"publisher","first-page":"G974","DOI":"10.1152\/ajpgi.2000.278.6.G974","volume":"278","author":"KS Murthy","year":"2000","unstructured":"Murthy KS, Teng B-Q, Zhou H, Jin J-G, Grider JR, Makhlouf GM. Gi\u20131\/Gi\u20132-dependent signaling by single-transmembrane natriuretic peptide clearance receptor. Am J Physiol Gastrointest Liver Physiol. 2000;278:G974\u201380.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10066_CR37","doi-asserted-by":"publisher","first-page":"22064","DOI":"10.1074\/jbc.M101587200","volume":"276","author":"M Pagano","year":"2001","unstructured":"Pagano M, Anand-Srivastava MB. Cytoplasmic domain of natriuretic peptide receptor C constitutes Gi activator sequences that inhibit adenylyl cyclase activity. J Biol Chem. 2001;276:22064\u201370.","journal-title":"J Biol Chem"},{"key":"10066_CR38","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cardiores.2007.02.032","volume":"74","author":"IC Villar","year":"2007","unstructured":"Villar IC, Panayiotou CM, Sheraz A, Madhani M, Scotland RS, Nobles M, et al. Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor. Cardiovasc Res. 2007;74:515\u201325.","journal-title":"Cardiovasc Res"},{"key":"10066_CR39","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1113\/jphysiol.2007.144253","volume":"586","author":"RA Rose","year":"2008","unstructured":"Rose RA, Giles WR. Natriuretic peptide C receptor signalling in the heart and vasculature. J Physiol. 2008;586:353\u201366.","journal-title":"J Physiol"},{"key":"10066_CR40","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.118.036344","volume":"139","author":"KJ Bubb","year":"2019","unstructured":"Bubb KJ, Aubdool AA, Moyes AJ, Lewis S, Drayton JP, Tang O, et al. Endothelial C-type natriuretic peptide is a critical regulator of angiogenesis and vascular remodeling. Circulation. 2019;139:1612\u201328.","journal-title":"Circulation"},{"key":"10066_CR41","volume":"11","author":"Y Nakagawa","year":"2022","unstructured":"Nakagawa Y, Nishikimi T. CNP, the third natriuretic peptide: its biology and significance to the cardiovascular system. Biology (Basel). 2022;11:986.","journal-title":"Biology (Basel)"},{"key":"10066_CR42","doi-asserted-by":"publisher","first-page":"36454","DOI":"10.1074\/jbc.M708596200","volume":"282","author":"P Moffatt","year":"2007","unstructured":"Moffatt P, Thomas G, Sellin K, Bessette M-C, Lafreni\u00e8re F, Akhouayri O, et al. Osteocrin is a specific ligand of the natriuretic peptide clearance receptor that modulates bone growth. J Biol Chem. 2007;282:36454\u201362.","journal-title":"J Biol Chem"},{"key":"10066_CR43","doi-asserted-by":"publisher","first-page":"16042","DOI":"10.1073\/pnas.1514250112","volume":"112","author":"E Subbotina","year":"2015","unstructured":"Subbotina E, Sierra A, Zhu Z, Gao Z, Koganti SRK, Reyes S, et al. Musclin is an activity-stimulated myokine that enhances physical endurance. Proc Natl Acad Sci U S A. 2015;112:16042\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10066_CR44","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.1172\/JCI94912","volume":"127","author":"Y Kanai","year":"2017","unstructured":"Kanai Y, Yasoda A, Mori KP, Watanabe-Takano H, Nagai-Okatani C, Yamashita Y, et al. Circulating osteocrin stimulates bone growth by limiting C-type natriuretic peptide clearance. J Clin Invest. 2017;127:4136\u201347.","journal-title":"J Clin Invest"},{"key":"10066_CR45","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1113\/EP091826","volume":"109","author":"NJA Scott","year":"2024","unstructured":"Scott NJA, Prickett TCR, Charles CJ, Espiner EA, Richards AM, Rademaker MT. Haemodynamic, hormonal and renal actions of osteocrin in normal sheep. Exp Physiol. 2024;109:1305\u201316.","journal-title":"Exp Physiol"},{"key":"10066_CR46","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1113\/EP092068","volume":"109","author":"R Sarzani","year":"2024","unstructured":"Sarzani R, Landolfo M, Giulietti F, Spannella F. Osteocrin\/musclin and the natriuretic peptides system: a novel focus in metabolism and cardiovascular prevention. Exp Physiol. 2024;109:1251\u20132.","journal-title":"Exp Physiol"},{"key":"10066_CR47","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1210\/clinem\/dgae450","volume":"110","author":"JS Nam","year":"2025","unstructured":"Nam JS, Cho E-S, Kwon YR, Park JS, Kim Y. Dynamic response of musclin, a myokine, to aerobic exercise and its interplay with natriuretic peptides and receptor C. J Clin Endocrinol Metab. 2025;110:1305\u201314.","journal-title":"J Clin Endocrinol Metab"},{"key":"10066_CR48","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/HYPERTENSIONAHA.113.01772","volume":"63","author":"Y Li","year":"2014","unstructured":"Li Y, Sarkar O, Brochu M, Anand-Srivastava MB. Natriuretic peptide receptor-C attenuates hypertension in spontaneously hypertensive rats: role of nitroxidative stress and Gi proteins. Hypertension. 2014;63:846\u201355.","journal-title":"Hypertension"},{"key":"10066_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113738","volume":"431","author":"Y-Y Lu","year":"2023","unstructured":"Lu Y-Y, Li S-J, Zhang Z, He S, Guo Y-T, Hong M-N, et al. C-atrial natriuretic peptide (ANP)4\u201323 attenuates renal fibrosis in deoxycorticosterone-acetate-salt hypertensive mice. Exp Cell Res. 2023;431:113738.","journal-title":"Exp Cell Res"},{"key":"10066_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.yjmcc.2015.02.019","volume":"82","author":"LL Wong","year":"2015","unstructured":"Wong LL, Wee ASY, Lim JY, Ng JYX, Chong JPC, Liew OW, et al. Natriuretic peptide receptor 3 (NPR3) is regulated by microRNA-100. J Mol Cell Cardiol. 2015;82:13\u201321.","journal-title":"J Mol Cell Cardiol"},{"key":"10066_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25489-3","author":"J Wang","year":"2018","unstructured":"Wang J, Tong KS, Wong LL, Liew O-W, Raghuram D, Richards AM, et al. MicroRNA-143 modulates the expression of natriuretic peptide receptor 3 in cardiac cells. Sci Rep. 2018. https:\/\/doi.org\/10.1038\/s41598-018-25489-3.","journal-title":"Sci Rep"},{"key":"10066_CR52","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1007\/s00018-020-03699-1","volume":"78","author":"J Roos","year":"2021","unstructured":"Roos J, Dahlhaus M, Funcke J-B, Kustermann M, Strauss G, Halbgebauer D, et al. MiR-146a regulates insulin sensitivity via NPR3. Cell Mol Life Sci. 2021;78:2987\u20133003.","journal-title":"Cell Mol Life Sci"},{"key":"10066_CR53","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.jacbts.2018.08.004","volume":"3","author":"M Mackasey","year":"2018","unstructured":"Mackasey M, Egom EE, Jansen HJ, Hua R, Moghtadaei M, Liu Y, et al. Natriuretic peptide receptor-C protects against angiotensin II-mediated sinoatrial node disease in mice. JACC Basic Transl Sci. 2018;3:824\u201343.","journal-title":"JACC Basic Transl Sci"},{"key":"10066_CR54","doi-asserted-by":"publisher","first-page":"e006863","DOI":"10.1161\/CIRCEP.118.006863","volume":"12","author":"HJ Jansen","year":"2019","unstructured":"Jansen HJ, Mackasey M, Moghtadaei M, Liu Y, Kaur J, Egom EE, et al. NPR-C (natriuretic peptide receptor-C) modulates the progression of angiotensin II-mediated atrial fibrillation and atrial remodeling in mice. Circ Arrhythm Electrophysiol. 2019;12:e006863.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10066_CR55","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/jcp.20793","volume":"209","author":"BK Huntley","year":"2006","unstructured":"Huntley BK, Sandberg SM, Noser JA, Cataliotti A, Redfield MM, Matsuda Y, et al. BNP-induced activation of cGMP in human cardiac fibroblasts: interactions with fibronectin and natriuretic peptide receptors. J Cell Physiol. 2006;209:943\u20139.","journal-title":"J Cell Physiol"},{"key":"10066_CR56","doi-asserted-by":"publisher","first-page":"eadd4222","DOI":"10.1126\/sciadv.add4222","volume":"9","author":"L Meng","year":"2023","unstructured":"Meng L, Lu Y, Wang X, Cheng C, Xue F, Xie L, et al. NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA\/PKG and inhibiting TGF-\u03b21\/Smad pathways. Sci Adv. 2023;9:eadd4222.","journal-title":"Sci Adv"},{"key":"10066_CR57","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/cvr\/cvy224","volume":"115","author":"D Rahmutula","year":"2019","unstructured":"Rahmutula D, Zhang H, Wilson EE, Olgin JE. Absence of natriuretic peptide clearance receptor attenuates TGF-\u03b21-induced selective atrial fibrosis and atrial fibrillation. Cardiovasc Res. 2019;115:357\u201372.","journal-title":"Cardiovasc Res"},{"key":"10066_CR58","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1161\/CIRCRESAHA.117.312624","volume":"122","author":"T Miyazaki","year":"2018","unstructured":"Miyazaki T, Otani K, Chiba A, Nishimura H, Tokudome T, Takano-Watanabe H, et al. A new secretory peptide of natriuretic peptide family, osteocrin, suppresses the progression of congestive heart failure after myocardial infarction. Circ Res. 2018;122:742\u201351.","journal-title":"Circ Res"},{"key":"10066_CR59","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41467-021-27634-5","volume":"13","author":"M Szaroszyk","year":"2022","unstructured":"Szaroszyk M, Kattih B, Martin-Garrido A, Trogisch FA, Dittrich GM, Grund A, et al. Skeletal muscle derived Musclin protects the heart during pathological overload. Nat Commun. 2022;13:149.","journal-title":"Nat Commun"},{"key":"10066_CR60","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/01.CIR.0000141802.29945.34","volume":"110","author":"A Hobbs","year":"2004","unstructured":"Hobbs A, Foster P, Prescott C, Scotland R, Ahluwalia A. Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia\/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide. Circulation. 2004;110:1231\u20135.","journal-title":"Circulation"},{"key":"10066_CR61","doi-asserted-by":"publisher","first-page":"107447","DOI":"10.1016\/j.phrs.2024.107447","volume":"209","author":"VJ Lowe","year":"2024","unstructured":"Lowe VJ, Aubdool AA, Moyes AJ, Dignam JP, Perez-Ternero C, Baliga RS, et al. Cardiomyocyte-derived C-type natriuretic peptide diminishes myocardial ischaemic injury by promoting revascularisation and limiting fibrotic burden. Pharmacol Res. 2024;209:107447.","journal-title":"Pharmacol Res"},{"key":"10066_CR62","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.124.325702","author":"X Wang","year":"2025","unstructured":"Wang X, Li J, Ma W, Meng L, Lu Y, Song J, et al. Podocyte NPRC deficiency attenuates glomerular fibrosis in diabetic mice. Circ Res. 2025. https:\/\/doi.org\/10.1161\/circresaha.124.325702.","journal-title":"Circ Res"},{"key":"10066_CR63","doi-asserted-by":"publisher","first-page":"e0319424","DOI":"10.1371\/journal.pone.0319424","volume":"20","author":"L Wang","year":"2025","unstructured":"Wang L, Tang Y, Buckley AF, Spurney RF. Podocyte specific knockout of the natriuretic peptide clearance receptor is podocyte protective in focal segmental glomerulosclerosis. PLoS ONE. 2025;20:e0319424.","journal-title":"PLoS ONE"},{"key":"10066_CR64","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15095","volume":"9","author":"L Wang","year":"2021","unstructured":"Wang L, Tang Y, Buckley AF, Spurney RF. Blockade of the natriuretic peptide clearance receptor attenuates proteinuria in a mouse model of focal segmental glomerulosclerosis. Physiol Rep. 2021;9:e15095.","journal-title":"Physiol Rep"},{"key":"10066_CR65","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1161\/HYPERTENSIONAHA.120.15636","volume":"77","author":"S Shao","year":"2021","unstructured":"Shao S, Li X-D, Lu Y-Y, Li S-J, Chen X-H, Zhou H-D, et al. Renal natriuretic peptide receptor-C deficiency attenuates NaCl cotransporter activity in angiotensin II\u2013induced hypertension. Hypertension. 2021;77:868\u201381.","journal-title":"Hypertension"},{"key":"10066_CR66","doi-asserted-by":"publisher","first-page":"100623","DOI":"10.1016\/j.jlr.2024.100623","volume":"65","author":"S-J Li","year":"2024","unstructured":"Li S-J, Wei J-Q, Kang Y-Y, Wang R-Q, Rong W-W, Zhao J-J, et al. Natriuretic peptide receptor-C perturbs mitochondrial respiration in white adipose tissue. J Lipid Res. 2024;65:100623.","journal-title":"J Lipid Res"},{"key":"10066_CR67","doi-asserted-by":"publisher","first-page":"9837","DOI":"10.1111\/jcmm.16931","volume":"25","author":"C Cheng","year":"2021","unstructured":"Cheng C, Xue F, Sui W, Meng L, Xie L, Zhang C, et al. Deletion of natriuretic peptide receptor C alleviates adipose tissue inflammation in hypercholesterolemic Apolipoprotein E knockout mice. J Cell Mol Med. 2021;25:9837\u201350.","journal-title":"J Cell Mol Med"},{"key":"10066_CR68","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aam6870","author":"W Wu","year":"2017","unstructured":"Wu W, Shi F, Liu D, Ceddia RP, Gaffin R, Wei W, et al. Enhancing natriuretic peptide signaling in adipose tissue, but not in muscle, protects against diet-induced obesity and insulin resistance. Sci Signal. 2017. https:\/\/doi.org\/10.1126\/scisignal.aam6870.","journal-title":"Sci Signal"},{"key":"10066_CR69","doi-asserted-by":"publisher","first-page":"e0293636","DOI":"10.1371\/journal.pone.0293636","volume":"18","author":"B Jia","year":"2023","unstructured":"Jia B, Hasse A, Shi F, Collins S. Exercise performance is not improved in mice with skeletal muscle deletion of natriuretic peptide clearance receptor. PLoS ONE. 2023;18:e0293636.","journal-title":"PLoS ONE"},{"key":"10066_CR70","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1177\/147323000803600314","volume":"36","author":"Y Liu","year":"2008","unstructured":"Liu Y, Huo X, Pang XF, Zong ZH, Meng X, Liu GL. Musclin inhibits insulin activation of Akt\/protein kinase B in rat skeletal muscle. J Int Med Res. 2008;36:496\u2013504.","journal-title":"J Int Med Res"},{"key":"10066_CR71","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.2337\/db20-0437","volume":"69","author":"W Zhang","year":"2020","unstructured":"Zhang W, Yang D, Yuan Y, Liu C, Chen H, Zhang Y, et al. Muscular G9a regulates muscle-liver-fat axis by musclin under overnutrition in female mice. Diabetes. 2020;69:2642\u201354.","journal-title":"Diabetes"},{"key":"10066_CR72","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.bbrc.2022.12.056","volume":"642","author":"SW Choi","year":"2023","unstructured":"Choi SW, Oh H, Park SY, Cho W, Abd El-Aty AM, Hacimuftuoglu A, et al. Myokine musclin alleviates lipid accumulation in 3T3-L1 adipocytes through PKA\/p38-mediated upregulation of lipolysis and suppression of lipogenesis. Biochem Biophys Res Commun. 2023;642:113\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"10066_CR73","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.trsl.2022.12.005","volume":"255","author":"L Wang","year":"2023","unstructured":"Wang L, Tang Y, Herman MA, Spurney RF. Pharmacologic blockade of the natriuretic peptide clearance receptor promotes weight loss and enhances insulin sensitivity in type 2 diabetes. Transl Res. 2023;255:140\u201351.","journal-title":"Transl Res"},{"key":"10066_CR74","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1097\/CM9.0000000000000752","volume":"133","author":"X-L Zhu","year":"2020","unstructured":"Zhu X-L, Zhang T, Xu Z-Q, Ma X-C, Wang Z-J, Zou C-W, et al. High salt-induced weakness of anti-oxidative function of natriuretic peptide receptor-C and podocyte damage in the kidneys of Dahl rats. Chin Med J (Engl). 2020;133:1182\u201391.","journal-title":"Chin Med J (Engl)"},{"key":"10066_CR75","doi-asserted-by":"publisher","first-page":"e72004","DOI":"10.1371\/journal.pone.0072004","volume":"8","author":"Y-X Li","year":"2013","unstructured":"Li Y-X, Cheng K-C, Asakawa A, Kato I, Sato Y, Amitani H, et al. Role of musclin in the pathogenesis of hypertension in rat. PLoS ONE. 2013;8:e72004.","journal-title":"PLoS ONE"},{"key":"10066_CR76","doi-asserted-by":"publisher","first-page":"e76183","DOI":"10.1371\/journal.pone.0076183","volume":"8","author":"J El Andalousi","year":"2013","unstructured":"El Andalousi J, Li Y, Anand-Srivastava MB. Natriuretic peptide receptor-C agonist attenuates the expression of cell cycle proteins and proliferation of vascular smooth muscle cells from spontaneously hypertensive rats: Role of GI proteins and MAPkinase\/PI3kinase signaling. PLoS ONE. 2013;8:e76183.","journal-title":"PLoS ONE"},{"key":"10066_CR77","doi-asserted-by":"publisher","first-page":"H3144","DOI":"10.1152\/ajpheart.00327.2006","volume":"291","author":"S Hashim","year":"2006","unstructured":"Hashim S, Li Y, Anand-Srivastava MB. Small cytoplasmic domain peptides of natriuretic peptide receptor-C attenuate cell proliferation through Gi\u03b1 protein\/MAP kinase\/PI3-kinase\/AKT pathways. Am J Physiol Heart Circ Physiol. 2006;291:H3144\u201353.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10066_CR78","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41392-023-01560-y","volume":"8","author":"C Cheng","year":"2023","unstructured":"Cheng C, Zhang J, Li X, Xue F, Cao L, Meng L, et al. NPRC deletion mitigated atherosclerosis by inhibiting oxidative stress, inflammation and apoptosis in ApoE knockout mice. Signal Transduct Target Ther. 2023;8:290.","journal-title":"Signal Transduct Target Ther"},{"key":"10066_CR79","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/1440-1681.12251","volume":"41","author":"SA Almeida","year":"2014","unstructured":"Almeida SA, Cardoso CC, Orellano LAA, Reis AM, Barcelos LS, Andrade SP. Natriuretic peptide clearance receptor ligand (C-ANP4\u201323) attenuates angiogenesis in a murine sponge implant model. Clin Exp Pharmacol Physiol. 2014;41:691\u20137.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10066_CR80","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1161\/ATVBAHA.124.322350","volume":"45","author":"AA Aubdool","year":"2025","unstructured":"Aubdool AA, Moyes AJ, Perez-Ternero C, Baliga RS, Sanghera JS, Syed MT, et al. Endothelium- and fibroblast-derived C-type natriuretic peptide prevents the development and progression of aortic aneurysm. Arterioscler Thromb Vasc Biol. 2025;45:1044\u201363.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10066_CR81","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.biopha.2017.07.027","volume":"93","author":"EE-A Egom","year":"2017","unstructured":"Egom EE-A, Feridooni T, Pharithi RB, Khan B, Shiwani HA, Maher V, et al. A natriuretic peptides clearance receptor\u2019s agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure. Biomed Pharmacother. 2017;93:1144\u201350.","journal-title":"Biomed Pharmacother"},{"key":"10066_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/pul2.12270","author":"BD Guarino","year":"2023","unstructured":"Guarino BD, Dado CD, Kumar A, Braza J, Harrington EO, Klinger JR. Deletion of the Npr3 gene increases severity of acute lung injury in obese mice. Pulm Circ. 2023. https:\/\/doi.org\/10.1002\/pul2.12270.","journal-title":"Pulm Circ"},{"key":"10066_CR83","doi-asserted-by":"publisher","first-page":"107870","DOI":"10.1016\/j.phrs.2025.107870","volume":"219","author":"JP Dignam","year":"2025","unstructured":"Dignam JP, Aubdool AA, Lowe VR, Perez-Ternero C, Moyes AJ, Nahal RS, et al. Endothelium-derived C-type natriuretic peptide offsets the pathogenesis of pulmonary hypertension. Pharmacol Res. 2025;219:107870.","journal-title":"Pharmacol Res"},{"key":"10066_CR84","doi-asserted-by":"publisher","first-page":"156050","DOI":"10.1016\/j.metabol.2024.156050","volume":"162","author":"F Jiang","year":"2025","unstructured":"Jiang F, Li X, Lin L, Li M, Zheng J. NPRC promotes hepatic steatosis via USP30-mediated deubiquitination of C\/EBP\u03b2. Metabolism. 2025;162:156050.","journal-title":"Metabolism"},{"key":"10066_CR85","doi-asserted-by":"publisher","first-page":"gae579","DOI":"10.1093\/pnasnexus\/pgae579","volume":"4","author":"C Perez-Ternero","year":"2025","unstructured":"Perez-Ternero C, Li W, Aubdool AA, Goldin RD, Loy J, Devalia K, et al. Endogenous C-type natriuretic peptide offsets the pathogenesis of steatohepatitis, hepatic fibrosis, and portal hypertension. PNAS Nexus. 2025;4:gae579.","journal-title":"PNAS Nexus"},{"key":"10066_CR86","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/oby.2004.44","volume":"12","author":"R Sarzani","year":"2004","unstructured":"Sarzani R, Strazzullo P, Salvi F, Iacone R, Pietrucci F, Siani A, et al. Natriuretic peptide clearance receptor alleles and susceptibility to abdominal adiposity. Obes Res. 2004;12:351\u20136.","journal-title":"Obes Res"},{"key":"10066_CR87","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1177\/1479164116675493","volume":"14","author":"W-J Chen","year":"2017","unstructured":"Chen W-J, Liu Y, Sui Y-B, Zhang B, Zhang X-H, Yin X-H. Increased circulating levels of musclin in newly diagnosed type 2 diabetic patients. Diab Vasc Dis Res. 2017;14:116\u201321.","journal-title":"Diab Vasc Dis Res"},{"key":"10066_CR88","doi-asserted-by":"publisher","first-page":"156211","DOI":"10.1016\/j.cyto.2023.156211","volume":"167","author":"J Zhang","year":"2023","unstructured":"Zhang J, Shi J, Cheng Z, Hu W. The correlation of serum musclin with diabetic nephropathy. Cytokine. 2023;167:156211.","journal-title":"Cytokine"},{"key":"10066_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s12986-017-0199-x","author":"W-J Chen","year":"2017","unstructured":"Chen W-J, Liu Y, Sui Y-B, Yang H-T, Chang J-R, Tang C-S, et al. Positive association between musclin and insulin resistance in obesity: evidence of a human study and an animal experiment. Nutr Metab (Lond). 2017. https:\/\/doi.org\/10.1186\/s12986-017-0199-x.","journal-title":"Nutr Metab (Lond)"},{"key":"10066_CR90","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3803\/EnM.2021.1104","volume":"36","author":"YL S\u00e1nchez","year":"2021","unstructured":"S\u00e1nchez YL, Yepes-Calder\u00f3n M, Valbuena L, Mil\u00e1n AF, Trillos-Almanza MC, Granados S, et al. Musclin is related to insulin resistance and body composition, but not to body mass index or cardiorespiratory capacity in adults. Endocrinol Metab. 2021;36:1055\u201368.","journal-title":"Endocrinol Metab"},{"key":"10066_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.114367","volume":"29","author":"R Wen","year":"2026","unstructured":"Wen R, Yang Y, Wang H, Teng Y, Zhao B, Zhu H, et al. The myokine musclin in metabolic syndrome: pathological links and exercise interventions. iScience. 2026;29:114367.","journal-title":"iScience"},{"key":"10066_CR92","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20165129","author":"J Yu","year":"2016","unstructured":"Yu J, Zheng J, Liu XF, Feng ZL, Zhang XP, Cao LL, et al. Exercise improved lipid metabolism and insulin sensitivity in rats fed a high-fat diet by regulating glucose transporter 4 (GLUT4) and musclin expression. Braz J Med Biol Res. 2016. https:\/\/doi.org\/10.1590\/1414-431x20165129.","journal-title":"Braz J Med Biol Res"},{"key":"10066_CR93","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14823","author":"M Shimomura","year":"2021","unstructured":"Shimomura M, Horii N, Fujie S, Inoue K, Hasegawa N, Iemitsu K, et al. Decreased muscle-derived musclin by chronic resistance exercise is associated with improved insulin resistance in rats with type 2 diabetes. Physiol Rep. 2021. https:\/\/doi.org\/10.14814\/phy2.14823.","journal-title":"Physiol Rep"},{"key":"10066_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39710-z","author":"L Jin","year":"2023","unstructured":"Jin L, Han S, Lv X, Li X, Zhang Z, Kuang H, et al. The muscle-enriched myokine Musclin impairs beige fat thermogenesis and systemic energy homeostasis via Tfr1\/PKA signaling in male mice. Nat Commun. 2023. https:\/\/doi.org\/10.1038\/s41467-023-39710-z.","journal-title":"Nat Commun"},{"key":"10066_CR95","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.molmet.2016.12.010","volume":"6","author":"A Gl\u00f6de","year":"2017","unstructured":"Gl\u00f6de A, Naumann J, Gnad T, Cannone V, Kilic A, Burnett JC Jr, et al. Divergent effects of a designer natriuretic peptide CD-NP in the regulation of adipose tissue and metabolism. Mol Metab. 2017;6:276\u201387.","journal-title":"Mol Metab"},{"key":"10066_CR96","doi-asserted-by":"publisher","first-page":"e2116470119","DOI":"10.1073\/pnas.2116470119","volume":"119","author":"C Perez-Ternero","year":"2022","unstructured":"Perez-Ternero C, Aubdool AA, Makwana R, Sanger GJ, Stimson RH, Chan LF, et al. C-type natriuretic peptide is a pivotal regulator of metabolic homeostasis. Proc Natl Acad Sci U S A. 2022;119:e2116470119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10066_CR97","doi-asserted-by":"publisher","first-page":"100941","DOI":"10.1016\/j.jbc.2021.100941","volume":"297","author":"F Shi","year":"2021","unstructured":"Shi F, Simandi Z, Nagy L, Collins S. Diet-dependent natriuretic peptide receptor C expression in adipose tissue is mediated by PPAR\u03b3 via long-range distal enhancers. J Biol Chem. 2021;297:100941.","journal-title":"J Biol Chem"},{"key":"10066_CR98","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12933-024-02456-z","volume":"23","author":"R Kaimori","year":"2024","unstructured":"Kaimori R, Nishida H, Tamura M, Kuroki K, Murata K, Kawamura K, et al. Obesity cardiomyopathy could contribute to sudden cardiac death: a Japanese epidemiological morphological study. Cardiovasc Diabetol. 2024;23:378.","journal-title":"Cardiovasc Diabetol"},{"key":"10066_CR99","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122:624\u201338.","journal-title":"Circ Res"},{"key":"10066_CR100","unstructured":"Naruko T, Ueda M, Haze K. Natriuretic peptide receptor expression in human failing hearts. Circulation 1997;96."},{"key":"10066_CR101","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.cardiores.2004.07.004","volume":"64","author":"M Kuhn","year":"2004","unstructured":"Kuhn M, Voss M, Mitko D, Stypmann J, Schmid C, Kawaguchi N, et al. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure. Cardiovasc Res. 2004;64:308\u201314.","journal-title":"Cardiovasc Res"},{"key":"10066_CR102","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-2362.2006.01596.x","volume":"36","author":"C Christoffersen","year":"2006","unstructured":"Christoffersen C, Bartels ED, Nielsen LB. Heart specific up-regulation of genes for B-type and C-type natriuretic peptide receptors in diabetic mice. Eur J Clin Invest. 2006;36:69\u201375.","journal-title":"Eur J Clin Invest"},{"key":"10066_CR103","doi-asserted-by":"publisher","first-page":"e85708","DOI":"10.1371\/journal.pone.0085708","volume":"9","author":"NL Pereira","year":"2014","unstructured":"Pereira NL, Redfield MM, Scott C, Tosakulwong N, Olson TM, Bailey KR, et al. A functional genetic variant (N521D) in natriuretic peptide receptor 3 is associated with diastolic dysfunction: the prevalence of asymptomatic ventricular dysfunction study. PLoS ONE. 2014;9:e85708.","journal-title":"PLoS ONE"},{"key":"10066_CR104","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.regpep.2010.12.009","volume":"167","author":"EN de Andrade","year":"2011","unstructured":"de Andrade EN, Gon\u00e7alves GKN, de Oliveira THC, Santos CSD, Souza CLSE, Firmes LB, et al. Natriuretic peptide system: a link between fat mass and cardiac hypertrophy and hypertension in fat-fed female rats. Regul Pept. 2011;167:149\u201355.","journal-title":"Regul Pept"},{"key":"10066_CR105","doi-asserted-by":"publisher","first-page":"H1970","DOI":"10.1152\/ajpheart.00893.2003","volume":"286","author":"RA Rose","year":"2004","unstructured":"Rose RA, Lomax AE, Kondo CS, Anand-Srivastava MB, Giles WR. Effects of C-type natriuretic peptide on ionic currents in mouse sinoatrial node: a role for the NPR-C receptor. Am J Physiol Heart Circ Physiol. 2004;286:H1970\u20137.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10066_CR106","doi-asserted-by":"publisher","DOI":"10.1111\/dme.70042","author":"J-W Lee-Boey","year":"2025","unstructured":"Lee-Boey J-W, Tan J-K, Lim Z-F, Zaccardi F, Khunti K, Ezzati M, et al. Obesity-related glomerulopathy: how it happens and future perspectives. Diabet Med. 2025. https:\/\/doi.org\/10.1111\/dme.70042.","journal-title":"Diabet Med"},{"key":"10066_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-025-01171-3","author":"V Martinez Leon","year":"2025","unstructured":"Martinez Leon V, Hilburg R, Susztak K. Mechanisms of diabetic kidney disease and established and emerging treatments. Nat Rev Endocrinol. 2025. https:\/\/doi.org\/10.1038\/s41574-025-01171-3.","journal-title":"Nat Rev Endocrinol"},{"key":"10066_CR108","doi-asserted-by":"publisher","first-page":"11850","DOI":"10.1038\/s41598-024-61603-4","volume":"14","author":"D Dabaghie","year":"2024","unstructured":"Dabaghie D, Charrin E, Tonelius P, Rosengren B, Korkut G, Granqvist AB, et al. Unraveling the role of natriuretic peptide clearance receptor (NPR3) in glomerular diseases. Sci Rep. 2024;14:11850.","journal-title":"Sci Rep"},{"key":"10066_CR109","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1002\/ehf2.13002","volume":"7","author":"F Spannella","year":"2020","unstructured":"Spannella F, Giulietti F, Filipponi A, Sarzani R. Effect of sacubitril\/valsartan on renal function: a systematic review and meta-analysis of randomized controlled trials. ESC Heart Fail. 2020;7:3487\u201396.","journal-title":"ESC Heart Fail"},{"key":"10066_CR110","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1113\/JP275856","volume":"597","author":"C Willson","year":"2019","unstructured":"Willson C, Watanabe M, Tsuji-Hosokawa A, Makino A. Pulmonary vascular dysfunction in metabolic syndrome. J Physiol. 2019;597:1121\u201341.","journal-title":"J Physiol"},{"key":"10066_CR111","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1210\/endrev\/bnaa025","volume":"42","author":"WB Horton","year":"2021","unstructured":"Horton WB, Barrett EJ. Microvascular dysfunction in diabetes mellitus and cardiometabolic disease. Endocr Rev. 2021;42:29\u201355.","journal-title":"Endocr Rev"},{"key":"10066_CR112","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1177\/002215540205000606","volume":"50","author":"VH Casco","year":"2002","unstructured":"Casco VH, Veinot JP, Kuroski de Bold ML, Masters RG, Stevenson MM, de Bold AJ. Natriuretic peptide system gene expression in human coronary arteries. J Histochem Cytochem. 2002;50:799\u2013809.","journal-title":"J Histochem Cytochem"},{"key":"10066_CR113","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.atherosclerosis.2005.01.023","volume":"181","author":"T Naruko","year":"2005","unstructured":"Naruko T, Itoh A, Haze K, Ehara S, Fukushima H, Sugama Y, et al. C-Type natriuretic peptide and natriuretic peptide receptors are expressed by smooth muscle cells in the neointima after percutaneous coronary intervention. Atherosclerosis. 2005;181:241\u201350.","journal-title":"Atherosclerosis"},{"key":"10066_CR114","doi-asserted-by":"publisher","first-page":"33662","DOI":"10.18632\/oncotarget.9358","volume":"7","author":"Q Hu","year":"2016","unstructured":"Hu Q, Liu Q, Wang S, Zhen X, Zhang Z, Lv R, et al. NPR-C gene polymorphism is associated with increased susceptibility to coronary artery disease in Chinese Han population: a multicenter study. Oncotarget. 2016;7:33662\u201374.","journal-title":"Oncotarget"},{"key":"10066_CR115","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.pharmthera.2004.08.011","volume":"105","author":"RS Scotland","year":"2005","unstructured":"Scotland RS, Ahluwalia A, Hobbs AJ. C-type natriuretic peptide in vascular physiology and disease. Pharmacol Ther. 2005;105:85\u201393.","journal-title":"Pharmacol Ther"},{"key":"10066_CR116","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4172\/2472-4971.1000131","volume":"1","author":"MA Zayed","year":"2016","unstructured":"Zayed MA, Harring SD, Abendschein DR, Vemuri C, Lu D, Detering L, et al. Natriuretic peptide receptor-C is up-regulated in the intima of advanced carotid artery atherosclerosis. J Med Surg Pathol. 2016;1:131.","journal-title":"J Med Surg Pathol"},{"key":"10066_CR117","doi-asserted-by":"publisher","DOI":"10.1155\/ijhy\/9972031","author":"R Harpe","year":"2025","unstructured":"Harpe R, de Rogne L, Nyberg T, Cronj\u00e9 M, Burgess HT, Karhunen S, et al. Associations of genetically predicted NPR3 and NPR2 perturbation and preeclampsia risk: a two-sample Mendelian randomization analysis. Int J Hypertens. 2025. https:\/\/doi.org\/10.1155\/ijhy\/9972031.","journal-title":"Int J Hypertens"},{"key":"10066_CR118","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.125.25938","author":"AJ Moyes","year":"2026","unstructured":"Moyes AJ, Sand C, Young L, P\u00e9rez-Ternero C, Salam AT, Baliga RS, et al. C-type natriuretic peptide preserves vascular and cardiac function in sepsis. Hypertension. 2026. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.125.25938.","journal-title":"Hypertension"},{"key":"10066_CR119","first-page":"1","volume":"9","author":"V Agrawal","year":"2019","unstructured":"Agrawal V, Fortune N, Yu S, Fuentes J, Shi F, Nichols D, et al. Natriuretic peptide receptor C contributes to disproportionate right ventricular hypertrophy in a rodent model of obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension. Pulm Circ. 2019;9:1\u201312.","journal-title":"Pulm Circ"},{"key":"10066_CR120","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1111\/j.1743-6109.2008.00775.x","volume":"5","author":"A Kun","year":"2008","unstructured":"Kun A, Kiraly I, Pataricza J, Marton Z, Krassoi I, Varro A, et al. C-type natriuretic peptide hyperpolarizes and relaxes human penile resistance arteries. J Sex Med. 2008;5:1114\u201325.","journal-title":"J Sex Med"},{"key":"10066_CR121","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1172\/JCI74281","volume":"124","author":"AJ Moyes","year":"2014","unstructured":"Moyes AJ, Khambata RS, Villar I, Bubb KJ, Baliga RS, Lumsden NG, et al. Endothelial C-type natriuretic peptide maintains vascular homeostasis. J Clin Invest. 2014;124:4039\u201351.","journal-title":"J Clin Invest"},{"key":"10066_CR122","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/hmg\/ddx375","volume":"27","author":"M Ren","year":"2018","unstructured":"Ren M, Ng FL, Warren HR, Witkowska K, Baron M, Jia Z, et al. The biological impact of blood pressure-associated genetic variants in the natriuretic peptide receptor C gene on human vascular smooth muscle. Hum Mol Genet. 2018;27:199\u2013210.","journal-title":"Hum Mol Genet"},{"key":"10066_CR123","doi-asserted-by":"publisher","first-page":"8966","DOI":"10.3390\/ijms22168966","volume":"22","author":"G Shen","year":"2021","unstructured":"Shen G, Hu S, Zhao Z, Zhang L, Ma Q. C-type natriuretic peptide ameliorates vascular injury and improves neurological outcomes in neonatal hypoxic-ischemic brain injury in mice. Int J Mol Sci. 2021;22:8966.","journal-title":"Int J Mol Sci"},{"key":"10066_CR124","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41575-025-01045-z","volume":"22","author":"CD Byrne","year":"2025","unstructured":"Byrne CD, Armandi A, Pellegrinelli V, Vidal-Puig A, Bugianesi E. \u039cetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment. Nat Rev Gastroenterol Hepatol. 2025;22:314\u201328.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10066_CR125","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMra2412865","volume":"393","author":"G Targher","year":"2025","unstructured":"Targher G, Valenti L, Byrne CD. Metabolic dysfunction\u2013associated steatotic liver disease. N Engl J Med. 2025;393:683\u201398.","journal-title":"N Engl J Med"},{"key":"10066_CR126","first-page":"728","volume":"65","author":"OA Sanchez","year":"2016","unstructured":"Sanchez OA, Lazo-Elizondo M, Zeb I, Tracy RP, Bradley R, Duprez DA, et al. Computerized tomography measured liver fat is associated with low levels of N-terminal pro-brain natriuretic protein (NT-proBNP). Multi-Ethnic Study Atherosclerosis Metabolism. 2016;65:728\u201335.","journal-title":"Multi-Ethnic Study Atherosclerosis Metabolism"},{"key":"10066_CR127","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.2337\/db09-0393","volume":"58","author":"K Miyashita","year":"2009","unstructured":"Miyashita K, Itoh H, Tsujimoto H, Tamura N, Fukunaga Y, Sone M, et al. Natriuretic peptides\/cGMP\/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes. 2009;58:2880\u201392.","journal-title":"Diabetes"},{"key":"10066_CR128","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jacc.2006.10.040","volume":"49","author":"AY Chang","year":"2007","unstructured":"Chang AY, Abdullah SM, Jain T, Stanek HG, Das SR, McGuire DK, et al. Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study. J Am Coll Cardiol. 2007;49:109\u201316.","journal-title":"J Am Coll Cardiol"},{"key":"10066_CR129","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jacc.2011.03.042","volume":"58","author":"CSP Lam","year":"2011","unstructured":"Lam CSP, Cheng S, Choong K, Larson MG, Murabito JM, Newton-Cheh C, et al. Influence of sex and hormone status on circulating natriuretic peptides. J Am Coll Cardiol. 2011;58:618\u201326.","journal-title":"J Am Coll Cardiol"},{"key":"10066_CR130","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1210\/en.2007-0572","volume":"149","author":"NO Belo","year":"2008","unstructured":"Belo NO, Sairam MR, Dos Reis AM. Impairment of the natriuretic peptide system in follitropin receptor knockout mice and reversal by estradiol: implications for obesity-associated hypertension in menopause. Endocrinology. 2008;149:1399\u2013406.","journal-title":"Endocrinology"},{"key":"10066_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147800","volume":"25","author":"F Werner","year":"2024","unstructured":"Werner F, Naruke T, S\u00fclzenbr\u00fcck L, Sch\u00e4fer S, R\u00f6sch M, V\u00f6lker K, et al. Auto\/paracrine C-type natriuretic peptide\/cyclic GMP signaling prevents endothelial dysfunction. Int J Mol Sci. 2024;25:7800.","journal-title":"Int J Mol Sci"},{"key":"10066_CR132","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10741-024-10471-1","volume":"30","author":"P Rajzer","year":"2025","unstructured":"Rajzer P, Biegus J. Sacubitril\/valsartan in a wide spectrum of heart failure patients (from mechanisms of action to outcomes in specific populations). Heart Fail Rev. 2025;30:387\u2013405.","journal-title":"Heart Fail Rev"},{"key":"10066_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22194-z","author":"R Stinkens","year":"2018","unstructured":"Stinkens R, van der Kolk BW, Jordan J, Jax T, Engeli S, Heise T, et al. The effects of angiotensin receptor neprilysin inhibition by sacubitril\/valsartan on adipose tissue transcriptome and protein expression in obese hypertensive patients. Sci Rep. 2018. https:\/\/doi.org\/10.1038\/s41598-018-22194-z.","journal-title":"Sci Rep"},{"key":"10066_CR134","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/cpt.455","volume":"101","author":"J Jordan","year":"2017","unstructured":"Jordan J, Stinkens R, Jax T, Engeli S, Blaak EE, May M, et al. Improved insulin sensitivity with angiotensin receptor neprilysin inhibition in individuals with obesity and hypertension. Clin Pharmacol Ther. 2017;101:254\u201363.","journal-title":"Clin Pharmacol Ther"},{"key":"10066_CR135","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-022-00944-4","author":"M Nikolic","year":"2022","unstructured":"Nikolic M, Novakovic J, Ramenskaya G, Kokorekin V, Jeremic N, Jakovljevic V. Cooling down with Entresto. Can sacubitril\/valsartan combination enhance browning more than coldness? Diabetol Metab Syndr. 2022. https:\/\/doi.org\/10.1186\/s13098-022-00944-4.","journal-title":"Diabetol Metab Syndr"},{"key":"10066_CR136","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oeaf031","author":"JJ Bakhos","year":"2025","unstructured":"Bakhos JJ, Saliba Y, Hajal J, Achkouty G, Oskaridjian H, Albuquerque M, et al. Inhibiting atrial natriuretic peptide clearance reduces myocardial fibrosis and improves cardiac function in diabetic rats. Eur Heart J Open. 2025. https:\/\/doi.org\/10.1093\/ehjopen\/oeaf031.","journal-title":"Eur Heart J Open"},{"key":"10066_CR137","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0939-4753(03)80018-2","volume":"13","author":"P Dess\u00ec-Fulgheri","year":"2003","unstructured":"Dess\u00ec-Fulgheri P, Sarzani R, Rappelli A. Role of the natriuretic peptide system in lipogenesis\/lipolysis. Nutr Metab Cardiovasc Dis. 2003;13:244\u20139.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10066_CR138","doi-asserted-by":"publisher","first-page":"17466","DOI":"10.1038\/s41598-021-96970-9","volume":"11","author":"H Kimura","year":"2021","unstructured":"Kimura H, Nagoshi T, Oi Y, Yoshii A, Tanaka Y, Takahashi H, et al. Treatment with atrial natriuretic peptide induces adipose tissue browning and exerts thermogenic actions in vivo. Sci Rep. 2021;11:17466.","journal-title":"Sci Rep"},{"key":"10066_CR139","doi-asserted-by":"publisher","first-page":"E512","DOI":"10.1152\/ajpendo.00341.2024","volume":"329","author":"EL Larsen","year":"2025","unstructured":"Larsen EL, Andersen U\u00d8, van Hall G, Lundby C, Burnett JC Jr, Goetze JP, et al. Effects of physiological doses of atrial natriuretic peptide on lipolysis, ketogenesis, and glucose metabolism in men. Am J Physiol Endocrinol Metab. 2025;329:E512\u201321.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10066_CR140","doi-asserted-by":"publisher","first-page":"5495","DOI":"10.1021\/acs.jmedchem.1c01974","volume":"65","author":"RJ Smith","year":"2022","unstructured":"Smith RJ, Perez-Ternero C, Conole D, Martin C, Myers SH, Hobbs AJ, et al. A series of substituted bis-aminotriazines are activators of the natriuretic peptide receptor C. J Med Chem. 2022;65:5495\u2013513.","journal-title":"J Med Chem"},{"key":"10066_CR141","doi-asserted-by":"publisher","first-page":"26365","DOI":"10.1021\/acs.jmedchem.5c02467","volume":"68","author":"ALB Kodal","year":"2025","unstructured":"Kodal ALB, Ewald J, Poulsen C, Bonde MFB, Kirchhoff JE, Poulsen S, et al. A once-weekly C-type natriuretic peptide for treatment of heart failure with preserved ejection fraction. J Med Chem. 2025;68:26365\u201382.","journal-title":"J Med Chem"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-026-10066-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-026-10066-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-026-10066-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:02:03Z","timestamp":1790445723000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-026-10066-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":141,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10066"],"URL":"https:\/\/doi.org\/10.1007\/s11154-026-10066-1","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}